Thema
Cost-effectiveness
Journal Article
14
Pneumococcal conjugate vaccine
6
Letter
4
Pneumococcal disease
3
Vaccination
3
Canada
2
HIV
2
PCV10
2
PCV13
2
Pneumonia
2
Vaccines
2
4CMenB
1
Acute otitis media
1
Adherence
1
Algeria
1
Antiretroviral therapy
1
Argentina
1
Australia
1
Budget impact
1
COVID-19
1
Cabotegravir
1
Carbapenem non-susceptible
1
Carbapenem resistance
1
Caregiver burden
1
Children vaccination
1
Colistin
1
Colombia
1
Cost-utility analysis
1
Costs
1
Disease burden
1
Dolutegravir
1
Economic consequences
1
Economic evaluation
1
Economic modeling
1
Economic value
1
Egypt
1
Finland
1
Germany
1
Gram-negative infection
1
Health care utilization
1
Health economics
1
Health technology assessment
1
Hepatitis C
1
Hepatitis C
1
High-risk infants
1
Hospitalization
1
Human rotavirus vaccine
1
Imipenem/cilastatin/relebactam
1
Immunoprophylaxis
1
mehr ...